Cardiac arrest

There are 244 papers on cardiac arrest in aging research: 5 trials and 185 observational studies in people, 19 in animals, 21 reviews. The newest story, Nov 17, 2026: “Anorexia nervosa linked to more cardiovascular hospitalizations”.

Disease

244 papers study it150 more mention it45 findings

51 new papers in 30 daysSee all 394 papers on cardiac arrest

At a glance

Human cohorts link frailty with higher cardiac arrest risk and older age with higher risk during acute coronary syndrome. Cardiac arrest is linked with higher mortality in older people with thoracic vertebral fractures. SGLT2 inhibitor use is associated with lower arrest risk in type 2 diabetes, but a heart-failure cohort after TAVR shows no clear link.

45 findings in 43 papers from 2016 to 2026, 12 of them since June 2026

“PPSV23 vaccination is associated with reduced mortality and cardiovascular events in elderly patients with HFrEF”
Cardiovascular Outcomes of PPSV23 Vaccination in Elderly Patients with Heart Failure with Reduced Ejection Fraction; a Propensity Matched Cohort StudyAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.11797
  • Human trial5
  • Humans185
  • Animals16
  • Model organisms3
  • In silico5

Interventions

6

SGLT2 inhibitors

no changein humans1downin humans1RR 0.5–1.12

2 studies
  1. SGLT2 inhibitors were not clearly linked with cardiac arrest in humans (heart failure patients after TAVR, propensity score-matched cohort) (4.2% vs. 3.8%; RR 1.120 (95% CI 0.660-1.900)).

    “cardiac arrest (4.2% vs. 3.8%; RR=1.120, 95% CI: 0.660-1.900, p=0.674)”

    Humansheart failure patients after TAVR, propensity score-matched cohortn = 660

    SGLT2 inhibitors improve clinical outcomes in patients with heart failure undergoing transcatheter aortic valve replacement: real world evidence from the trinetx database

    ESC Congress 2026 abstract

  2. SGLT2 inhibitors decrease cardiac arrest in chronic kidney disease (RR 0.50 (95% CI 0.26-0.95)).

    “cardiac arrest was reduced in CKD (RR 0.50, 95% CI 0.26-0.95, p=0.03)”

    Reviewin chronic kidney disease

    Effects of SGLT2 Inhibitors on Cardiac Arrhythmias: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    ADA Scientific Sessions 2026 abstract

More on SGLT2 inhibitors

Semaglutide

upin humans1

1 study
  1. Semaglutide is linked with higher cardiac arrest in humans (reports compared with tirzepatide reports in FAERS) (ROR 3.42).

    “cardiac arrest (ROR: 3.42)”

    Humansreports compared with tirzepatide reports in FAERSJanuary 2022 to March 2026

    Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)

    Cureus

More on Semaglutide

Statins

no changein humans1

1 study
  1. Statins were not clearly linked with cardiac arrest in humans after traumatic injury.

    “Risk-adjusted outcomes of interest were statistically similar between the statin and control cohorts for mortality, venous thromboembolism, myocardial infarction, stroke, and cardiac arrest.”

    Humansafter traumatic injury

    Introduction to entropy balancing: A case study on the association between statin therapy and outcomes after traumatic injury

    Surgery

More on Statins

Bariatric surgery

no changein humans1

1 study
  1. Bariatric surgery was not clearly linked with cardiac arrest in humans (obese patients with hypertrophic cardiomyopathy).

    “Rates of arrhythmias and cardiac arrest were similar between both groups.”

    Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females

    Cardiovascular outcomes following bariatric surgery in obese patients with hypertrophic cardiomyopathy: A multicenter propensity-matched analysis

    American heart journal plus : cardiology research and practice

More on Bariatric surgery

Metabolically unhealthy obesity

no changein humans1OR 1.01

1 study
  1. Metabolically unhealthy obesity was not clearly linked with cardiac arrest in cancer-related pulmonary embolism hospitalizations (OR 1.01, 95% CI 0.80-1.26, P = 0.892).

    “or MUHO (OR: 1.01, 95% CI: 0.80-1.26, P = 0.892) patients when compared to non-obese individuals”

    Humansin cancer-related pulmonary embolism hospitalizations

    Impact of metabolically healthy and metabolically unhealthy obesity on cardiac arrest and mortality in pulmonary embolism hospitalizations in elderly patients with cancer

    Lung India : official organ of Indian Chest Society

More on Metabolically unhealthy obesity

Metabolically healthy obesity

no changein humans1OR 1.14

1 study
  1. Metabolically healthy obesity was not clearly linked with cardiac arrest in cancer-related pulmonary embolism hospitalizations (OR 1.14, 95% CI 0.66-1.98, P = 0.892).

    “no significant differences in the rates of cardiac arrest were observed among MHO (OR: 1.14, 95% CI: 0.66-1.98, P = 0.892)”

    Humansin cancer-related pulmonary embolism hospitalizations

    Impact of metabolically healthy and metabolically unhealthy obesity on cardiac arrest and mortality in pulmonary embolism hospitalizations in elderly patients with cancer

    Lung India : official organ of Indian Chest Society

More on Metabolically healthy obesity

Upstream

2

HFpEF hospitalization temporal trend

upin humans1

1 study
  1. HFpEF hospitalization temporal trend is linked with higher cardiac arrest in humans (hospitalized with HFpEF) (1.1% to 1.5% (36% relative increase)).

    “Incidence rose from 1.1% in 2016 to 1.5% in 2020 (36% relative increase).”

    Humanshospitalized with HFpEF2016 to 2020

    Nationwide Trends in Demographics, Comorbidities, and Mortality Among Elderly Patients with Heart Failure with Preserved Ejection Fraction Hospitalized with Cardiac Arrest

    Journal of personalized medicine

Obesity

no changein humans1

1 study
  1. Obesity was not clearly linked with cardiac arrest in humans (septic shock).

    “Cardiac arrest rates remained unchanged”

    Humansseptic shock

    Impact of Metabolically Healthy and Unhealthy Obesity on Outcomes of Sepsis Complicated by Septic Shock in Elderly Patients

    Journal of intensive care medicine

Associations

27

SGLT2 inhibitors

downin humans5OR 0.55

5 studies
  1. SGLT2 inhibitors are associated with cardiac arrest in humans (OR 0.55, 95% CI 0.41–0.75).

    “SGLT2 inhibitor use was also associated with lower odds of cardiac arrest (OR 0.55; 95% CI 0.41-0.75)”

    HumansPatients with diabetes and bioprosthetic heart valves; propensity-score-matched comparison with non-usersApproximately 2.8±1.8 years

    SGLT2 Inhibitor Use and Bioprosthetic Valve Re-Intervention in Patients with Diabetes

    AHA Scientific Sessions 2026 abstract

  2. SGLT2 inhibitors are associated with cardiac arrest in humans (Type 2 diabetes; compared with DPP-4 inhibitors after propensity score matching) (1.0% vs 1.4%; HR 0.616, 95% CI 0.587–0.646).

    “cardiac arrest (1.0% vs 1.4%; risk ratio 0.671, 95% CI 0.640-0.703; HR 0.616, 95% CI 0.587-0.646)”

    HumansType 2 diabetes; compared with DPP-4 inhibitors after propensity score matching5 years

    Comparative Cardiovascular Outcomes of SGLT2 Inhibitors versus DPP-4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matched Real-World Analysis

    AHA Scientific Sessions 2026 abstract

  3. SGLT2 inhibitors are associated with cardiac arrest in degenerative aortic stenosis (0.82% vs. 1.21% HR 0.71; 95% CI 0.582-0.867; p < 0.001).

    “cardiac arrest (0.82% vs. 1.21% HR 0.71; 95% CI 0.582-0.867; p < 0.001)”

    Humansin degenerative aortic stenosis

    Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study

    Journal of clinical medicine

  4. SGLT2 inhibitors are linked with a lower risk of cardiac arrest in humans (HR 1.409 (95% CI 1.135–1.750) for non-users).

    “while the HR for cardiac arrest was 1.409 (95% CI: 1.135–1.750)”

    Humansin adults with type 2 diabetes undergoing VT ablation; SGLT2i non-users compared with users, propensity-matched3 years

    Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Patients undergoing Ventricular Tachycardia (VT) Ablation: A Propensity-Matched Cohort Study

    AHA Scientific Sessions 2025 abstract

  5. SGLT2 inhibitors lower the risk of cardiac arrest in humans (HR 0.63 to 0.85 across studies).

    “estimates consistently reported a lower risk with estimates that ranged from HR 0.63 (95% CI 0.59-0.68) to HR 0.85 (95% CI 0.82-0.88)”

    Review

    Sodium Glucose Co-Transporter 2 Inhibitors and Ventricular Arrhythmias in Patients with Type 2 Diabetes: A Systematic Review of Observational Studies

    Drug safety

More on SGLT2 inhibitors

GLP-1 receptor agonists

downin humans4RR 0.33–0.5

4 studies
  1. GLP-1 receptor agonists are linked with a lower risk of cardiac arrest in humans after 1:1 propensity score matching, 1-year follow-up (RR 0.33 (95% CI 0.31–0.37)).

    “GLP-1 RAs group of patients were having significantly lower risk of cardiac arrest (RR, 0.33 (95% CI: 0.31–0.37), p<0.01)”

    Humansafter 1:1 propensity score matching, 1-year follow-up1 yearn = 342,753

    Association between Glucagon-like peptide-1 receptor agonists and risk of Arrhythmias: A Contemporary Real-World Analysis

    AHA Scientific Sessions 2025 abstract

  2. GLP-1 receptor agonists are linked with a lower risk of cardiac arrest in humans (propensity-matched cohort; GLP-1RA started within 14 days after TAVI) (HR 0.452).

    “and cardiac arrest (HR 0.452 [95% CI, 0.213-0.960]; p=0.034)”

    Humanspropensity-matched cohort; GLP-1RA started within 14 days after TAVI1 yearn = 930

    GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Undergoing TAVI: A Real-World Cohort Study

    AHA Scientific Sessions 2025 abstract

  3. GLP-1 receptor agonists are linked with a lower risk of cardiac arrest in patients with MASLD, hyperlipidemia and heart failure, after propensity score matching (HR 0.580; 95% CI 0.475-0.709; p < 0.001).

    “cardiac arrest (HR 0.580; 95% CI 0.475-0.709; p < 0.001)”

    Humansin patients with MASLD, hyperlipidemia and heart failure, after propensity score matching5-year follow-upn = 6,310

    SAT-669 Impact of GLP-1 agonist in patients with heart failure and dyslipidemia affected by Metabolic Dysfunction-Associated Steatotic Liver Disease: A prospective case control study

    ENDO 2025 abstract

  4. GLP-1 receptor agonists are linked with a lower risk of cardiac arrest in humans (0.8% vs 1.6%; RR 0.5 (95% CI 0.3-0.7)).

    “the +GLP group experienced significantly lower rates of cardiac arrest (0.8% vs 1.6%, RR 0.5, 95% CI 0.3-0.7, P < 0.01)”

    Humans1 year

    Perioperative glucagon-like Peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: A large retrospective cohort study with two year follow up

    Injury

More on GLP-1 receptor agonists

Testosterone

upin humans2HR 1.41–1.83

2 studies
  1. Testosterone is associated with cardiac arrest in humans (HR 1.83, 95% CI 1.45–2.31).

    “Off-label TT was further associated with higher risk of cardiac arrest (HR 1.83, 95% CI 1.45–2.31; p<0.001)”

    HumansMen with diabetes; off-label testosterone therapy compared with therapy in confirmed hypogonadismDay 1 to 10 yearsmales

    Off-label testosterone linked to heart risks in men with diabetes

    ESC Congress 2026 abstract

  2. Testosterone is linked with a higher risk of cardiac arrest in humans (without evidence of hypogonadism vs with evidence of hypogonadism) (HR 1.41, 1.23-1.61).

    “cardiac arrest (HR 1.41, 1.23-1.61)”

    Humanswithout evidence of hypogonadism vs with evidence of hypogonadismup to 10 yearsmales

    Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men

    EBioMedicine

More on Testosterone

Mortality

upin humans2HR 7.6

2 studies
  1. Cardiac arrest is linked with a higher risk of mortality in geriatric subgroup with thoracic vertebral fractures (OR = 51.74).

    “cardiac arrest (OR = 51.74)”

    Humansin geriatric subgroup with thoracic vertebral fracturesn = 16,276

    The fourth column in thoracic vertebral fractures: concomitant thoracic cage injuries and mortality in 27,814 inpatient cases from the german national DRG database

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

  2. Cardiac arrest is linked with a higher risk of mortality in humans (HR 7.60, 95% CI 1.49 to 38.66).

    “Nonagenarians who experienced a cardiac arrest had the highest hazard of death in the intensive care unit (HR 7.60, 95% confidence interval (CI) 1.49 to 38.66, P = 0.015)”

    Humansn = 89

    Characteristics and outcomes of nonagenarians admitted to the intensive care unit: A single-centre observational study

    Anaesthesia and intensive care

PPSV23 vaccination

downin humans1OR 0.71

1 study
  1. PPSV23 vaccination is associated with cardiac arrest in humans (OR 0.71, 95% CI 0.67-0.75).

    “PPSV23 vaccination is associated with reduced mortality and cardiovascular events in elderly patients with HFrEF”

    HumansHFrEF (LVEF ≤40%); vaccination within 12 months of diagnosis versus unvaccinated patients after propensity score matching3 years

    Shot tied to fewer deaths in older adults with weak-pump heart failure

    AHA Scientific Sessions 2026 abstract

More on PPSV23 vaccination

Definite ARVC

upin humans1HR 27.3

1 study
  1. Definite ARVC is associated with cardiac arrest in humans (Definite ARVC among pathogenic/likely pathogenic variant carriers) (HR 27.3).

    “Longitudinally, cardiac arrest risk was confined to Definite ARVC (HR 27.3, p<0.05).”

    HumansDefinite ARVC among pathogenic/likely pathogenic variant carriers

    Prevalence and disease expression of pathogenic and likely pathogenic variants associated with ARVC in a large cohort

    ESC Congress 2026 abstract

More on Definite ARVC

GPSMult

upin humans1HR 1.35

1 study
  1. GPSMult is associated with cardiac arrest in humans (HR 1.35, 95% CI 1.21–1.52 per 1-SD higher GPSMult).

    “a cardiovascular polygenic risk score was associated with future cardiac arrest independent of measured baseline risk factors.”

    HumansMultivariable adjustment for age, sex, smoking, hypertension, diabetes, and ApoB/ApoA1 ratioPer 1-SD higher GPSMultMedian follow-up of 27.3 yearsn = 29,004

    Long-term risk of cardiac arrest according to a cardiovascular polygenic risk score in a population-based cohort

    ESC Congress 2026 abstract

More on GPSMult

5-factor Modified Frailty Index

upin humans1OR 2.99

1 study
  1. 5-factor Modified Frailty Index predicts cardiac arrest in humans (chordoma surgery) (OR 2.99, 95% CI 1.51–5.96).

    “cardiac arrest (OR 2.99, 95% CI 1.51–5.96; p = 0.0018; AUC 0.72)”

    Humanschordoma surgeryn = 1,245

    Frailty Stratification by the MFI-5 Index Predicts Serious Complications in Chordoma Surgery

    Journal of Neurological Surgery Part B Skull Base

More on 5-factor Modified Frailty Index

Random forest classifier

upin silico1+99% accuracy

1 study
  1. random forest classifier predicts cardiac arrest in silico (prediction using time series ECG data) (99.06% accuracy).

    “Among machine learning models, the Random Forest classifier performed best, achieving an accuracy of 99.06% and highlighting the reliability of ensemble learning methods.”

    In silicoprediction using time series ECG data

    Time series electrocardiography (ECG) data for early prediction of cardiac arrest

    Scientific reports

Convolutional neural network

upin silico1+100% accuracy

1 study
  1. convolutional neural network predicts cardiac arrest in silico (prediction using time series ECG data) (99.89% accuracy).

    “Experimental results demonstrate the superior performance of deep learning models, with a Convolutional Neural Network (CNN) achieving an accuracy of 99.89%.”

    In silicoprediction using time series ECG data

    Time series electrocardiography (ECG) data for early prediction of cardiac arrest

    Scientific reports

All 27

Trial sponsors

Funding

10 grants since 2017

National Institute of Neurological Disorders and Stroke$2.8MNational Heart, Lung, and Blood Institute$949KUS Department of Veterans Affairs

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 11Jan 2026: 14Feb 2026: 16Mar 2026: 17Apr 2026: 2May 2026: 12Jun 2026: 5Jul 2026: 8Aug 2026: 7Sep 2026: 8Oct 2026: 17Nov 2026: 36153 papers in 12 months
Canadian Journal of Psychiatry Revue Canadienne de Psychiatrie

Anorexia nervosa linked to more cardiovascular hospitalizations

Anorexia nervosa was linked to 1.43 times the risk of cardiovascular hospitalization in men and 2.23 times in women, compared with matched controls.Anorexia nervosa was linked to 1.43 times the risk of cardiovascular hospitalization in men and 2.23 times in women, compared with matched controls.

Cohort · 7,332 peopleAnorexia nervosa
AHA Scientific Sessions 2026 Abstract

Diabetes medicines linked to better blood sugar than metformin

Normal blood sugar returned in 37.3% of recipients versus 29.3% taking metformin in a matched comparison of adults with prediabetes and obesity.Normal blood sugar returned in 37.3% of recipients versus 29.3% taking metformin in a matched comparison of adults with prediabetes and obesity.

Cohort · 256,492 peopleDiabetes mellitus
AHA Scientific Sessions 2026 Abstract

Leading causes of death differed by stroke type in survivors

Heart disease accounted for 31.6% of deaths after blocked-vessel strokes versus 15.9% after bleeding strokes, where cancer led at 38.9%.Heart disease accounted for 31.6% of deaths after blocked-vessel strokes versus 15.9% after bleeding strokes, where cancer led at 38.9%.

Cohort · 625 peopleStroke
AHA Scientific Sessions 2026 Abstract

Disrupted daily rhythms linked to cardiovascular events

Over a median 3.3 years, participants with the most disrupted daily rhythms had 84% higher relative cardiovascular risk than those with the most stable rhythms.Over a median 3.3 years, participants with the most disrupted daily rhythms had 84% higher relative cardiovascular risk than those with the most stable rhythms.

Cohort · 8,790 peopleCardiovascular disease
AHA Scientific Sessions 2026 Abstract

Higher frailty linked to hospital deaths on heart-lung support

Deaths occurred in 49.3% of hospitalizations with high frailty scores versus 45.6% with low scores among adults on heart-lung support.Deaths occurred in 49.3% of hospitalizations with high frailty scores versus 45.6% with low scores among adults on heart-lung support.

Cohort · 34,260 peopleBiomarkers
AHA Scientific Sessions 2026 Abstract

High social disadvantage linked to heart risk like mild artery calcium

Cardiovascular event rates were 3.77 per 1,000 person-years with high social disadvantage and no artery calcium, versus 3.12 with mild calcium and high disadvantage.Cardiovascular event rates were 3.77 per 1,000 person-years with high social disadvantage and no artery calcium, versus 3.12 with mild calcium and high disadvantage.

Cohort · 2,901 peoplePopulations

See all 394 papers on cardiac arrest